Compare VIAV & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIAV | TWST |
|---|---|---|
| Founded | 1923 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 9.2B |
| IPO Year | 1996 | 2018 |
| Metric | VIAV | TWST |
|---|---|---|
| Price | $34.86 | $124.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | $32.66 | ★ $46.88 |
| AVG Volume (30 Days) | ★ 4.0M | 1.6M |
| Earning Date | 04-29-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,518,300,000.00 | $376,572,000.00 |
| Revenue This Year | $37.78 | $18.91 |
| Revenue Next Year | $10.64 | $15.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 40.03 | 20.32 |
| 52 Week Low | $11.54 | $23.30 |
| 52 Week High | $60.43 | $155.44 |
| Indicator | VIAV | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 37.66 | 52.47 |
| Support Level | $31.11 | $39.81 |
| Resistance Level | $35.61 | $155.44 |
| Average True Range (ATR) | 2.04 | 9.53 |
| MACD | -0.50 | -2.41 |
| Stochastic Oscillator | 8.55 | 35.61 |
Viavi Solutions Inc is a world-wide leader in test and measurement and optical technologies. Its test and measurement, and resilient Position, Navigation and Timing (PNT) solutions enable and secure critical infrastructure ranging from data center ecosystems and communication networks to military, aerospace, railway and first responder communications. In addition, it develop and advance technologies used in high-volume optical applications across anti-counterfeiting, consumer electronics, aerospace, industrial and automotive end markets. The company's segments are Network and Service Enablement (NSE); and Optical Security and Performance Products (OSP). Majority of revenue comes from NSE segment. It has presence in Americas, Asia-Pacific, and EMEA. Majority of revenue is from America.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.